1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Merle, P.; Rimassa, L.; Ryoo, B.; Cicin, I.; Harris, W.; Banu, E.; Sarker, D.; Tan, B.; Van Vlierberghe, H.; Sen, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib plus MEK inhibitor binimetinib plus anti-epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer
    Meeting Abstract

    Van Cutsem, E.; Cuyle, P.; Huijberts, S.; Schellens, J.; Elez, E.; Yaeger, R.; Fakih, M.; Montagut, C.; Peeters, M.; Desai, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Treatment and testing patterns among patients with HER2+ advanced/metastatic gastric, esophageal or gastroesophageal junction (GEJ) adenocarcinoma in the United States
    Meeting Abstract

    Janjigian, Y.; Hess, L.; Zhu, Y.; Fang, Y.; Liepa, A.; Kuder, C.; Chin, S.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability-high (MSI-H) colorectal cancer: KEYNOTE-164
    Meeting Abstract

    Le, D.; Kavan, P.; Kim, T.; Burge, M.; Van Cutsem, E.; Hara, H.; Boland, P.; Van Laethem, J.; Geva, R.; Taniguchi, H.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress
    Meeting Abstract

    Bang, Y.; Van Cutsem, E.; Fuchs, C.; Ohtsu, A.; Tabernero, J.; Ilson, D.; Hyung, W.; Strong, V.; Goetze, T.; Yoshikawa, T.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress
    Meeting Abstract

    Cheng, A.; Abou-Alfa, G.; Ren, Z.; Assenat, E.; Cubillo, A.; Pluntke, S.; Rimassa, L.; Ross, P.; Wyrwicz, L.; Hou, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Androgen deprivation therapy is associated with prolongation of QTc interval in men with prostate cancer
    Journal Article

    Gagliano-Jucá, T.; Travison, T. G.; Kantoff, P. W.; Nguyen, P. L.; Taplin, M. E.; Kibel, A. S.; Huang, G.; Bearup, R.; Schram, H.; Manley, R.; more...
    Journal of the Endocrine Society (2018)

    Fulltext@MSK | Save
  • 30 immunotherapy in advanced NSCLC - from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: Results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)
    Journal Article

    de Marinis, F.; Ciardiello, F.; Baas, P.; Crinò, L.; Giaccone, G.; Grossi, F.; Hellmann, M. D.; Mok, T. S. K.; Lena, H.; Paz-Ares, L.; more...
    ESMO Open (2018)

    Fulltext@MSK | Save
  • Hearing loss in adult survivors of childhood cancer treated with radiotherapy
    Journal Article

    Khan, A.; Budnick, A.; Barnea, D.; Feldman, D. R.; Oeffinger, K. C.; Tonorezos, E. S.
    Children (2018)

    Fulltext@MSK | Save
  • A novel adverse event associated with olaparib therapy in a patient with metastatic breast cancer
    Journal Article

    Wheelden, M.; Cream, L.; Sivik, J.; Robson, M.
    Case Reports in Oncological Medicine (2018)

    Fulltext@MSK | Save